Small logo Subscribe to leading news on impact investing. Learn More
The Brief Originals Dealflow Signals The Impact Alpha Impact Voices Podcasts Agents of Impact Open
What's Next Capital on the Frontier Measure Better Investing in Racial Equity Beyond Trade-offs Impact en las Americas New Revivalists
Local and Inclusive Climate Finance Catalytic Capital Frontier Finance Best Practices Geographies
Slack Conference Calls Events Contribute
The Archive ImpactSpace The Accelerator Selection Tool Network Map
About Us FAQ Calendar Pricing and Payment Policy Privacy Policy Terms of Service Agreement Contact Us
Locavesting Entrepreneurship Gender Smart Return on Inclusion Good Jobs Creative economy Opportunity Zones Investing in place Housing New Schooled Well Being People on the Move Faith and investing Inclusive Fintech
Clean Energy Farmer Finance Soil Wealth Conservation Finance Financing Fish
Innovative Finance
Personal Finance Impact Management
Africa Asia Europe Latin America Middle East Oceania/Australia China Canada India United Kingdom United States
Subscribe
Features
Series
Themes
Community
Data
Subscribe Log In
More

Backstage Capital backs Native American-run biotech firm Novoron



Novoron Bioscience was founded by neuroscientist Travis Stiles to develop therapies for central nervous system disorders like multiple sclerosis.

The company has been working with a National Institute of Health grant to develop a spinal cord nerve regeneration therapy. Backstage Capital announced on Twitter that it had invested an undisclosed amount in the company.

Backstage raised its second fund last year to invest in women and minority entrepreneurs, whose stake of total venture capital funding is in the low single digits. Its founder, Arlan Hamilton as a New Revivalist in the ImpactAlpha series with Village Capital.

Arlan Hamilton: The VC taking cold calls from underestimated entrepreneurs

You might also like...